GUTS Furnishes Press Release Reporting Quarterly Results for Q2

Rhea-AI Filing Summary

Fractyl Health, Inc. announced that it reported its financial results for the quarter ended June 30, 2025 and provided a corporate update, and the company furnished a related press release as Exhibit 99.1 to this Current Report. The filing states the press release is being "furnished" and therefore is not deemed "filed" for Section 18 liability purposes and is not incorporated by reference into other filings unless expressly stated.

The Current Report itself does not include the underlying financial figures or detailed metrics; investors must refer to the furnished Exhibit 99.1 press release for the actual results and any numerical detail.

Positive

• Disclosure provided: The company announced quarterly results and a corporate update, ensuring investors are informed that results have been released.
• Press release furnished as Exhibit 99.1: The company made the related press release available through the Current Report, directing readers to the source of substantive information.

Negative

• No financial figures in the 8-K text: The Current Report does not include numerical results or metrics; readers must access Exhibit 99.1 for details.
• Exhibit is furnished, not filed: The company expressly disclaims Section 18 filing liability and does not incorporate the exhibit by reference, which may limit regulatory protections for investors seeking incorporated disclosures.

Insights

Financial Analyst

TL;DR: Routine earnings disclosure furnished via press release; no figures included in the filing itself, limiting immediate analytical use.

The registrant announced quarterly results for the period ending June 30, 2025 and furnished a press release as Exhibit 99.1. Because the release is "furnished" and not "filed," the Current Report explicitly disclaims Section 18 liability and does not incorporate the release by reference. For analysts, the material event is the availability of the press release, but without numbers in the 8-K text, models and valuation adjustments require the Exhibit content. This filing is procedural and neutral in impact until the Exhibit's figures are reviewed.

Corporate Governance Expert

TL;DR: Proper disclosure mechanics were followed; furnishing rather than filing limits legal exposure but provides less regulatory incorporation.

The Company furnished a press release reporting quarterly results and a corporate update and clarified that the press release is "furnished" and not "filed," which is a standard approach to limit Section 18 exposure. The 8-K identifies the press release as Exhibit 99.1 and lists the interactive cover page. From a governance and disclosure control perspective, this meets procedural obligations, but stakeholders should consult Exhibit 99.1 for substantive financial information because the 8-K text contains no numerical results or detailed metrics.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001572616false00015726162025-08-122025-08-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2025

Fractyl Health, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-41942	27-3553477
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
3 Van de Graaff Drive Suite 200
Burlington, Massachusetts				01803
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: (781) 902-8800

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.00001 par value per share		GUTS		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On August 12, 2025, Fractyl Health, Inc. announced its financial results for the quarter ended June 30, 2025 and provided a corporate update. A copy of the press release in connection with the announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in Item 2.02 of this Current Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibit relates to Item 2.02 and shall be deemed to be furnished, and not filed:

Exhibit No.		Description
99.1		Fractyl Health, Inc. Press Release dated August 12, 2025
104		Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Fractyl Health, Inc.
Date:	August 12, 2025	By:	/s/ Harith Rajagopalan
			Harith Rajagopalan, M.D., Ph.D. Co-Founder, Chief Executive Officer and Director (Principal Executive Officer)

FAQ

What did Fractyl Health (GUTS) announce in this 8-K?

The company announced it reported financial results for the quarter ended June 30, 2025 and provided a corporate update; a related press release is furnished as Exhibit 99.1.

Does this Current Report contain the actual financial numbers for Q2 2025?

No. The 8-K text does not include specific financial figures; investors must review Exhibit 99.1 (the press release) for the numerical results.

Is the press release in the 8-K considered "filed" with the SEC?

No. The filing states the press release is furnished and shall not be deemed "filed" for Section 18 of the Exchange Act, nor incorporated by reference except by specific reference in another filing.

Where can I find the press release mentioned in this 8-K?

The press release is attached to the Current Report as Exhibit 99.1; the 8-K lists that exhibit as the source of the announcement and update.

What should investors do to obtain the detailed results referenced in this filing?

Investors should obtain and review Exhibit 99.1 (the furnished press release) for the company's reported financial results and any detailed metrics or commentary.